Evidence map›Paper›PMID 29177635›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2018

The ArlRS two-component system is a regulator of Staphylococcus aureus-induced endothelial cell damage.

Kati Seidl, Michèle Leemann, Annelies S Zinkernagel

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Identification of Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kati SeidlDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Rämistr. 100, RAE U, 8091, Zurich, Switzerland. kati.seidlspirig@usz.ch.ORCID http://orcid.org/0000-0002-2484-6364
Michèle LeemannDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Rämistr. 100, RAE U, 8091, Zurich, Switzerland.
Annelies S ZinkernagelDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Rämistr. 100, RAE U, 8091, Zurich, Switzerland.
University of Zurich · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030_146295/1
6 · The paper itself

Abstract

Staphylococcus aureus endovascular infections retain a high morbidity and mortality despite antibiotics and supportive care. The destruction of endothelial cells (ECs) is a critical step in the pathogenesis of S. aureus endovascular infections. In order to better understand S. aureus-induced EC damage, we systematically screened a collection of two-component regulatory system mutants of methicillin-resistant S. aureus (MRSA) USA300 strain JE2 for damage induction in human umbilical vein ECs (HUVECs). This screen revealed that the two-component regulatory system ArlRS is required for maximum damage: arlRS inactivation leads to a > 70% reduction in damage. In a different genetic S. aureus background (RN6390, MSSA strain) arlRS inactivation had a smaller but also significant effect on EC damage. In both strains, the reduction in EC damage was accompanied by a significant reduction in internalization. In conclusion, we determined a novel role of ArlRS in S. aureus-induced EC damage, which will help to better understand the pathogenesis of S. aureus endovascular infection.

Indexed as

Bacterial ProteinsCells, CulturedHumansHuman Umbilical Vein Endothelial CellsMethicillin-Resistant Staphylococcus aureusProtein KinasesStaphylococcal InfectionsTrans-ActivatorsAgr protein, Staphylococcus aureusArlR protein, Staphylococcus aureusArlS protein, Staphylococcus aureusBacterial ProteinsProtein KinasesTrans-Activators

Identifiers

PMID29177635
OpenAlexW2770879483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.